About 2.8 million tons of styrene were produced in the United States in 1973, slightly less than toluene and slightly more than vinyl chloride (1) . Polystyrene and styrene polymers (butadiene-styrene, acryonitritile-butadienestyrene for example) production totaled 2.2 million tons in 1974 and was expected to rise to 11 millions tons by the year 2000 (2) . The other major use of styrene is as a crosslinking agent in polyester resin manufacture; 30-40% of the volume of fresh resin may be styrene (3) .
Physically, styrene monomer is a volatile liquid (see Table 1 ); most human exposure is to this form. During the commonly used hand layup glass fiber-polyester resin process, evaporation rates of styrene are on the order of 50 g/m2 in 30 min; exposures are of the order of 100-200 ppm (3) (4) (5) time-weighted average (TWA) over a several hour period. Levels in styrene production or polymerization are less readily obtained. Barcotti (6) gave a level of 192 ppm during polymerization, 25- to several hundred to a few thousand parts per million (7, 8) .
The partition coefficient of styrene favors steady-state concentrations which are highest in fat and decrease progressively from fat to blood to water to air (9, 10) (Table 1) . Styrene has been found in the fat of occupationally exposed workers (11) . October 1976
Dynamically, styrene is well absorbed through the lungs (about 70-90% of that contained in the alveolar ventilation) (12, 13) . Over a concentration range of 0-350 ppm and over a period of several hours, the same proportion of inspired styrene continues to be absorbed (12) . Styrene is also well absorbed through the skin (14) . Blood styrene continues to rise over time during this period (13, 15) .
Styrene
Styrene Styrene oxide glycol 0 OH OH I R-CH-CH2 -e R-CH-CH2,-* R-CH-CH2 -. R = CO HsStyrene oxide has been shown to be a basesubstitution mutagen; other metabolites were not found to be mutagenic (18) . The evidence for the mutagenicity of styrene itself is mostly negative (18) ; however, Vainio (19) has stated that styrene may be mutagenic in the presence of a microsomal system. It may be that styrene oxide is produced by microsomes.
The metabolism of styrene takes place in the liver; it is stimulated by phenobarbital and suppressed by coadministered toluene (20) . At low level styrene exposure (1-50 ppm over few hours) an increase in mandelic acid excretion in the urine is detectable (4, 16, (21) (22) (23) , peaking about 4-5 hr after a 1-2 hr exposure. At high level exposure of about 100 ppm TWA (4, 16) , the excretion rate of the metabolites reaches a plateau. A significant increase in hippuric acid excretion occurs (16, 24) , an observation first noted for high exposure in 1944 (24) . This peak of hippuric acid excretion rate is delayed for about 20 hr (16).
Toxicology
The toxic effects of styrene were first reported for acute and chronic exposures in 1942 (25) . At Gut (26) found that the spontaneous motor activity in the rat decreased at levels of several hundred ppm for 8 hr. Studies in humans (see Table 2 ) have found related effects in acute experiments lasting a few hours at 800 ppm (24) . The subjects were grossly unsteady and drowsy, with nasal and eye irritation and a metallic taste in the mouth. They felt tense and depressed. In the range of 350 ppm irritation was still strong, and objective tests of coordination and dexterity (15) and reaction time were abnormal. Gamberale (27) also found that subjects felt affected and tense after exposure. At a level of 200 ppm, Oltramare (13) found increased reaction times in 30%; Gamberale (27) found no change. Irritative symptoms were present to 50-100 ppm (13, 15) , reaction time increases and subjective symptoms were inconsistently present (13, 15, 27) . Odor was noted to levels of 3-5 ppm, but irritation, increased reaction time, and subjective symptoms (13) were absent. Acute pulmonary function changes, or acute liver function changes have not been systematically examined in human subjects.
Environmental Health Perspectives (1) (3, 5, 13, (28) (29) (30) (31) . Some have studied copolymer production in synthetic rubber manufacture (32) (33) . A summary of a number of studies is given in Table 2 . Studies of styrene manufacturing and polymerization factory were reported only by Barsotti (6) in 1952. He found irritation, especially of skin and eyes, and complaints of decreased night vision. A slight leucopenia was present in some workers, possibly related to the presence of benzene in the plant. Katz (33) showed a high prevalence of liver and hematological changes in a synthetic rubber manufacturing plant.
Zielhuis (3) in reviewing the literature in 1962, stated that irritation of mucosa and nonspecific asthenia and lassitude were commonly found associated with industrial exposures to styrene. Hematological abnormalities were in 
Current Investigation
A styrene monomer and polymerization plant was studied, in which a large number of workers had had relatively pure styrene exposure for many years. This paper reports initial clinical findings in 494 workers. An investigation of the mortality experience of 563 long-term styrene workers is also currently underway.
The plant began in 1943 as a production facility for butadiene and styrene (see Fig. 1 ), manufacturing the monomers but not copolymerizing them. Butadiene was produced until about 1950. Styrene and butadiene were polymerized elsewhere into butadiene rubber. Since the 1950's the principal product has been polystyrene. Limited extrusion of polystyrene also is undertaken; the remainder of the polystyrene is extruded elsewhere. Over 90% of the polystyrene coffee cups in the United States comes from polystyrene manufactured in this plant. Since 1969 ethylbenzene has been the starting product. Little benzene has been present and that in specific areas, notably the benzene building and styrene monomer purification areas (see Fig. 2 ). Significantly less benzene exposure occurred during the [1963] [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] period. Some toluene is recovered, primarily as a side
Characteristics of Group
The group examined numbered 494. The median age was in the 40's, but because of hiring practices in the past, the distribution is bimodal (see Table 3 ). Males constituted 98% of the group. Table 4 shows in which year each of the workers was first employed. Relatively few workers were first employed in the late 1950's and early 1960's. From review of job descriptions and actual tasks performed by those in each job, an estimate of relative exposure was obtained (see Table 6 ). In developing this estimate, we utilized the experience of management and of workers and had available a NIOSH Health Hazard Evaluation (35) of the facility. Of the 488 production and maintenance members for which adequate occupational histories are available, 200 were judged currently to be in low exposure, and 288 in relatively high styrene exposure. Significant benzene exposure was thought to be a possibility in certain job categories, as marked. Analysis is by relative exposure and time. High exposure is defined as 80% or more of years having been spent in a high exposure job. The level of 90%o has been used as the dividing line for history of acute symptoms.
Results
Styrene at high concentrations (hundreds of ppm) produces a prenarcotic syndrome, described by the individual affected as being "lightheaded" or "drunk." An attempt was made to exclude prenarcosis due to other substances (such as pentane) which also cause the syndrome. Of the workers 13% overall had had at least one episode of prenarcosis (see Table 7 ). Those with high styrene exposure had significantly more prenarcosis than those with low exposure. Acute mucous membrane irritation is a common occurrence above levels of 50-100 ppm in experimental work with subjects never before exposed to styrene. Significant tolerance may develop in industrial populations. This fact may explain our failure to find differences in prevalence between relatively high and low styrene (see Table 8 ).
The workers were also asked if they ever had wheezing or tightness in the chest from styrene vapors. In this case 11%o of workers had such an episode. Significantly more high than low exposed workers had had this symptom (see Table 9 ).
Environmental Health Perspectives a Significant benzene exposure possible. The same pattern is present for recurrent symptoms, i.e., present weekly to monthly over a period of time (see Table 10 ) ; 12.1 % of the workers in the high styrene area versus 4.9% of those in low-styrene exposures had recurrent episodes. The prevalence of chronic bronchitis was investigated (see Table 11 ); 19% of the workers reported such symptoms. 
a Definition: cough and sputum production on most days for at least 3 months for at least 2 yr.
To eliminate the effect of smoking, nonsmokers were analyzed separately (see Table  12 ). Of the nonsmokers, 6% had symptoms consistent with chronic bronchitis. No trends were noted. We have seen such findings in other industrial populations. It is questionable whether styrene exposure had etiological importance in this population. 
a Definition: cough and sputum production on most days for at least 3 months for at least 2 years.
The prevalence of airway obstruction defined as FEV1/FVC < 75% was also investigated (see Table 13 ). Overall, 35.3% satisfied this criteria for obstruction; here, the high and low styrene groups were statistically different. Of the nonsmokers, 31.6%) had evidence of airways obstruction (see Table 14 ), although no October 1976 pattern consistent with a simple dose-response relationship was present. As expected, obstruction increased with years on the job among smokers (see Table 15 ). Overall, 5.9%' of the men had FVC < 80% predicted (see Table   16 ); restriction was not of significance in this group of workers. The x-rays were categorized by the ILO-U/C International Classification of Radiographs of Pneumoconiosis (see Table 17 ). Apart from those with history of previous coal or asbestos exposure there was no finding of significant radiological change; surely not at the level we have seen in vinyl chloride workers (31) . with known prior exposure to asHepatic function was investigated by using bilirubin, alkaline phosphatase, SGPT, GGTP, and SGOT as parameters (see Table 18 ). The distribution of the abnormal results was investigated. For this initial analysis, "abnormal" was defined as at or above the 96th percentile as compared with a group of 993 nonhospitalized men aged 40-44 tested at the same laboratory; 471 sets of results were available for analysis.
When tested for styrene (high and low) and duration, only GGTP showed a nonrandom pattern (see Table 19 ). Overall, 4.9%o were elevated: 6.7% in the high styrene and 2.8% in the low styrene groups. This difference was statistically significant. The difference shown Environmental Health Perspectives in the > 20 and < 20 yr groups is significant but needs to be adjusted for age-dependent increase in GGTP. When those with alcohol consumptions of more than 400 proof ounces (2 oz pure ethanol) per week are excluded (see Table  20 ), the differences increase between the low and high styrene groups. For those currently working, those with low styrene and high styrene with concurrent relatively low and high benzene are compared (see Table 21 ). No comparisons reach statistical significance, although both chemicals may have an effect on the prevalence of GGTP. No other patterns were observed when we analyzed other liver function tests in a similar manner. Hematological parameters investigated included hemoglobin, white blood count, and platelet count (see Table 22 ): 13.6% of the workers had hemoglobin levels below 14.0 g-%; 2.7%c had white blood counts below 4800; and 7.4% had platelet counts below 180,000. An- 
Discussion
The results of this clinical survey confirm styrene to be an irritant of the mucous membranes of the upper respiratory tract. The possibility that styrene may also be a significant lower respiratory irritant in occupational groups must also be considered. That 30% of the nonsmokers had FEV1/FVC < 75%, and that 12%o of the high exposed workers (compared to 4%o of the lower exposed) had repeated episodes of wheezing and/or tightness in the chest suggests an etiological relationship.
Serum y-glutanyl transpeptidase was higher among those with higher exposure, consistent with hepatic changes. Hematological findings did not yield evidence of significant marrow depression in this preliminary analysis.
In comparison with findings of studies (36, 37) done in a similar manner of workers exposed to another monomer, vinyl chloride, there was no evidence of characteristic vinyl chloride monomer changes such as Reynaud's syndrome, acroosteolysis, clinical hepatic disfunction, or skin changes No overt neoplasms were found in this survey.
Summary
Initial analysis of findings in a clinical survey of 494 workers at a styrene manufacturing, polymerization, and polystyrene extrusion facility has been undertaken. No unusual clinical patterns emerged, although styrene monomer is confirmed as an irritant and CNS depressant, and some changes in pulmonary function and in serum GGTP were found. An investigation of the mortality experience of workers at this facility is underway and will be reported later, as will findings of other studies performed during this survey of styrene-exposed workers.
